drugset / Trial / NCT01013116
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of specific subcutaneous immunotherapy with modified allergen extracts.
Timeline
- Start
- 2016-04
- Primary completion
- 2017-04
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | modified allergen extract of house dust mites | Unknown | — | Subcutaneous |